Posted by 18CAM.ORG on May 26, 2025 at 23:32:45:
In Reply to: Привет, дорогие друзья! Добро пожаловать на наш вебсайт, где у нас множество разных штук, коие могут для вас понадобиться. Я для вас поведаю, собственно что у нас тут крутого есть, но не ждите трудных слов и технических терминов, потому что я обыденный человек, как и вы! posted by WilliamRut on December 05, 2023 at 17:25:01:
Demasculinization may be produced through partial to full testosterone suppression or blockade using assorted doses of antiandrogens, progestogens, and/or gonadotropin-releasing hormone modulators. For example, non-binary transfeminine people may search an intermediate bodily and hormonal state between what's typical for males and females, might want substantial or full feminization and demasculinization with out breast development, may wish to have a extra sexually neutral or androgynous appearance, or might want for feminization but concomitant preservation of more male-typical sexual need and capability. Non-binary transfeminine people with these preferences can merely use standard transfeminine hormone therapy for his or her hormonal transition as opposed to more experimental and non-standard partial approaches. Transfeminine people who are non-binary usually desire totally different and more partial feminizing and demasculinizing changes compared to what happens with conventional transfeminine hormone therapy. Instead, we will only extrapolate from principle and research in different groups of people at the moment. Ada S. Cheung of Trans Health Research in Australia is a co-creator on the paper. Burshell, A. L., Anderson, S. J., Leib, E. S., Johnston, C. C., & Costantino, J. P. (1999). The effect of tamoxifen on pre and postmenopausal bone. Moghetti, P., Castello, R., Zamberlan, N., Rossini, M., Gatti, D., Negri, C., Tosi, F., Muggeo, M., & Adami, S. (1999). Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist.